e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Cardiovascular and metabolic consequences of sleep-disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of treatment of CSA/CSR on left ventricular ejection fraction in heart failure– a network meta-analysis
E. Schwarz (Zurich, Switzerland), F. Scherff (Zurich, Switzerland), S. Haile (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)
Source:
International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Session:
Cardiovascular and metabolic consequences of sleep-disordered breathing
Session type:
Thematic Poster
Number:
4327
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Schwarz (Zurich, Switzerland), F. Scherff (Zurich, Switzerland), S. Haile (Zurich, Switzerland), M. Kohler (Zurich, Switzerland). Effect of treatment of CSA/CSR on left ventricular ejection fraction in heart failure– a network meta-analysis. 4327
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Contribution of increased afterload to right ventricular ejection fraction in pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Characterization of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea syndrome with preserved left ventricular ejection fraction
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
When it all comes down to pressure: right ventricular ejection fraction at cardiac catheterisation
Source: Eur Respir J, 55 (3) 1902341; 10.1183/13993003.02341-2019
Year: 2020
Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension
Source: Eur Respir J 2007; 29: 622-623
Year: 2007
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Long-term outcomes in non invasive ventilation and low left ventricle ejection fraction
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019
A pressure-based single beat method for estimation of right ventricular ejection fraction: proof of concept
Source: Eur Respir J, 55 (3) 1901635; 10.1183/13993003.01635-2019
Year: 2020
Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 139-149
Year: 2015
Young males with pulmonary arterial hypertension have a high afterload and low right ventricular ejection fraction at presentation
Source: International Congress 2018 – On the right path: understanding and improving the function of an overloaded right heart ventricle
Year: 2018
Evaluation of right ventricular overload with the ratio of right ventricular end-diastolic area to left ventricular end-diastolic area in precapillary pulmonary hypertension: A cardiac MRI and catheterization study
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy
Source: Sleep and Breathing Conference 2021
Year: 2021
Right and left ventricular dysfunction in patients with COPD and heart failure
Source: Eur Respir J 2007; 30: Suppl. 51, 706s
Year: 2007
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2008; 31: 1160-1166
Year: 2008
Assessment of left ventricular function in COPD
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Right ventricular function at rest
Source: International Congress 2019 – PG18 Haemodynamics and right ventricular function during exercise
Year: 2019
Ventricular arrhythmia in heart failure patients with reduced ejection fraction and central sleep apnoea
Source: ERJ Open Res, 7 (3) 00147-2021; 10.1183/23120541.00147-2021
Year: 2021
Accurate monitoring of the right ventricular ejection fraction by echocardiography in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Objective quantification of right ventricular ejection fraction using new 3D echocardiographic software in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Lung function abnormalities in patients with heart failure and preserved ejection fraction
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept